Ari Moskowitz leads a team that focuses on the introduction of maternal and newborn health innovations, with the aim of reducing mortality and morbidity in low- and middle-income countries through pregnancy risk stratification. The team invests in areas including AI-assisted ultrasound imaging and wearable sensing platforms to enable appropriate planning and referrals through the pregnancy cycle.
Before joining the foundation in 2022, Ari spent 25 years in the medical device industry, including at Boston Scientific and Medtronic, where he worked on the development and commercialization of coronary ultrasound imaging, diagnostic tools, and vascular and neurological intervention devices. He was most recently based in Tokyo for three years, where he led product localization and portfolio strategies for the Asia Pacific region as vice president of technology and alliances.
Ari has a B.S. and an M.S. in biomedical engineering from Johns Hopkins University and the University of Texas Southwestern Medical Center, respectively.
Over the course of his career, Ari has worked with physicians and regulators around the world and forged practical co-development partnerships across companies and hospital networks to bring integrated health care solutions to clinical settings around the world.
More about the foundation
Learn about where we work around the globe and the programs we've created to address urgent issues in global health, global development, and education.
Read the latest stories, research, and news from across the foundation and subscribe to our weekly newsletter, The Optimist.